Cargando…
Whole gene sequencing identifies deep-intronic variants with potential functional impact in patients with hypertrophic cardiomyopathy
BACKGROUND: High throughput sequencing technologies have revolutionized the identification of mutations responsible for genetic diseases such as hypertrophic cardiomyopathy (HCM). However, approximately 50% of individuals with a clinical diagnosis of HCM have no causal mutation identified. This may...
Autores principales: | Mendes de Almeida, Rita, Tavares, Joana, Martins, Sandra, Carvalho, Teresa, Enguita, Francisco J., Brito, Dulce, Carmo-Fonseca, Maria, Lopes, Luís Rocha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5552324/ https://www.ncbi.nlm.nih.gov/pubmed/28797094 http://dx.doi.org/10.1371/journal.pone.0182946 |
Ejemplares similares
-
RNA Splicing Defects in Hypertrophic Cardiomyopathy: Implications for Diagnosis and Therapy
por: Ribeiro, Marta, et al.
Publicado: (2020) -
Prognostic relevance of exercise testing in hypertrophic cardiomyopathy. A systematic review
por: Rodrigues, Tiago, et al.
Publicado: (2021) -
Computational prediction of human deep intronic variation
por: Barbosa, Pedro, et al.
Publicado: (2023) -
Clinical significance of genetic variation in hypertrophic cardiomyopathy: comparison of computational tools to prioritize missense variants
por: Barbosa, Pedro, et al.
Publicado: (2022) -
Reevaluation of the South Asian MYBPC3(Δ25bp) Intronic Deletion in Hypertrophic Cardiomyopathy
por: Harper, Andrew R., et al.
Publicado: (2020)